Skip to content

Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.

Max M Owens, Shannon McNally, Tashia Petker, Michael T Amlung, Iris M. Balodis, Lawrence H Sweet, James MacKillop

Neuropsychopharmacology February 2019 DOI: 10.1038/s41386-018-0240-4 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational study (cross-sectional analysis within the Human Connectome Project) Peer reviewed
Sample size 1,038
Population Human Connectome Project participants
Measures visual N-back task, functional magnetic resonance imaging (fMRI), blood-activation-level-dependent (BOLD) signal
Topics Cannabis
Key findings A positive urine drug screen for THC was associated with worse working memory performance and differential brain response in working memory regions, with changes in task-positive and task-negative activation mediating this relationship. Lifetime cannabis use, age of first use, and other involvement indicators were not associated with working memory performance or brain response, which the authors interpret as suggesting short-term residual effects rather than long-term persistent effects.

Abstract

Worldwide, cannabis is one of the most widely used psychoactive substances and cannabis use has been implicated in poorer performance in several cognitive domains, including working memory (WM). However, the neural mechanisms underlying these WM decrements are not well understood and the current study investigated the association of cannabis involvement with WM performance and associated neural activation in the Human Connectome Project (N = 1038). Multiple indicators of cannabis involvement were examined in relation to behavioral performance and brain activity in a visual N-back task using functional magnetic resonance imaging. A positive urine drug screen for tetrahydocannabinol (THC+ status), the principal psychoactive constituent in cannabis, was associated with worse WM performance and differential brain response in areas previously linked to WM performance. Furthermore, decreases in blood-activation-level-dependent (BOLD) signal in WM task-positive brain regions and increases in task-negative regions mediated the relationship between THC+ status and WM performance. In contrast, WM performance and BOLD response during the N-back task were not associated with total lifetime cannabis use, age of first use, or other indicators of involvement, suggesting that the effects of cannabis on WM were short-term residual effects, rather than long-term persistent effects. These findings elucidate differential influences of cannabis involvement on neurocognition and have significant potential implications for occupational performance in diverse settings.

Comparable studies

Other cross-sectional and survey studies on cannabis, most cited first.

Study Year Design Participants
Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... 2011 Observational cross-sectional study n = 148
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... 2012 Cross-sectional survey n = 337

Citations in the library

Explore topics